Izote Biosciences reimagines solutions to the fermentation scale-up problem for the $24B bioprocess technology industry. We enable fermentation scale-up in the absence of oxygen, reducing CAPEX by 50%, OPEX by 36%, and overall raw material consumption. Izote Biosciences improves performance and process robustness compared to current aerobic fermentation processes and empowers users by adapting their existing workflows to our in-house production platforms. Izote Biosciences delivers a cost-effective solution to expeditiously develop and deploy the next generation of biomolecules and bioproducts. Izote Biosciences is at the forefront of the new oxygen-free bio-manufacturing era. We are engineering common production hosts (e.g. E. coli/Bacillus) with the ability to grow anaerobically. So both aerobic and anaerobic bugs will work with this technology. Also, since the metabolism produces some oxygen, manufacturing processes requiring oxygen should not be impacted.
→ Website
→ LinkedIn
COMPANY PROFILE: IZOTE BIOSCIENCES
Reducing inputs and increasing speed to product.
Unlock the bioeconomy through step-change improvements to the economics of industrial fermentation
FOUNDERS:
→ Victor Manuel Reyes-Umaña
→ Samuel Atwood
LAST FUNDING STAGE:
preSeed
VECTOR:
Biological Machines
2
Team Members
350K
Funding to Date
Delve deeper into the world of Biological Machines through our other inspiring articles or discover why we're also passionate about Human Machine Interaction and Machine to Machine Learning.
DIG DEEPER
Bee.
Bee Partners
50 Osgood Place
Suite 220A
San Francisco, CA 94133
LinkedIn: Bee Partners
Twitter: @BeePartners
© Bee Partners 2024